SR141716A is an inverse agonist at the human cannabinoid CB 1 receptor

Author： Landsman R.S.   Burkey T.H.   Consroe P.   Roeske W.R.   Yamamura H.I.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.334, Iss.1, 1997-09, pp. : 1-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A

By De Vry J.   Schreiber R.   Eckel G.   Jentzsch K.R.  

European Journal of Pharmacology, Vol. 483, Iss. 1, 2004-01 ,pp. : 55-63

Elsevier

Access to resources Recommend Favorite

The cannabinoid CB 1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2

By Darmani N.A.  

European Journal of Pharmacology, Vol. 430, Iss. 1, 2001-10 ,pp. : 49-58

Elsevier

Access to resources Recommend Favorite

Effects of the cannabinoid CB 1 receptor antagonist, SR141716A, after 9 -tetrahydrocannabinol withdrawal

By Beardsley P.M.   Martin B.R.  

European Journal of Pharmacology, Vol. 387, Iss. 1, 2000-11 ,pp. : 47-53

Elsevier

Access to resources Recommend Favorite

The cannabinoid CB 1 receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus

By Tzavara E.T.   Perry K.W.   Rodriguez D.E.   Bymaster F.P.   Nomikos G.G.  

European Journal of Pharmacology, Vol. 426, Iss. 3, 2001-08 ,pp. : 3-4

Elsevier

Access to resources Recommend Favorite

Discriminative stimulus effects in rats of SR-141716 (rimonabant), a cannabinoid CB1 receptor antagonist

By Järbe Torbjörn   Harris Michele   Li Chen   Liu Qian   Makriyannis Alexandros  

Psychopharmacology, Vol. 177, Iss. 1-2, 2004-12 ,pp. : 35-45

Springer Publishing Company

Access to resources Recommend Favorite